Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Correlation of CD30 Expression on Neoplastic Mast Cells in Systemic Mastocytosis Assessed By Immunohistochemistry Versus Multiparameter Flow Cytometry and Correlation to Clinical Parameters

Frauke Bellos, MD, Karl Sotlar, MD, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach, Wolfgang Kern, MD

Blood (2015) 126 (23): 1616.

https://doi.org/10.1182/blood.V126.23.1616.1616

Published: 2015

Journal Articles

Myeloid Nuclear Differentiation Antigen (MNDA) Expression: A Useful Marker in the Diagnosis of Myelodysplastic Syndromes By Flow Cytometry

Frauke Bellos, MD, Torsten Haferlach, Bruce H. Davis, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD

Blood (2015) 126 (23): 5235.

https://doi.org/10.1182/blood.V126.23.5235.5235

Published: 2015

Journal Articles

Assessment Of Human Equilibrative Nucleoside Transporter 1 (hENT1) – Expression By Flow Cytometry In Acute Myeloid Leukemia and Myelodysplastic Syndromes and Correlation To Clinical Outcome In Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy

Frauke Bellos, MD, Bruce H. Davis, MD, Naomi B. Culp, PhD, Birgitte Booij, PhD, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Wolfgang Kern, MD

Blood (2013) 122 (21): 2582.

https://doi.org/10.1182/blood.V122.21.2582.2582

Published: 2013

Journal Articles

Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency

Verena Patterer, PhD, Melanie Zenger, Susanne Schnittger, PhD, Sandra Weissmann, PhD, Franziska Poetzinger, Alexander Kohlmann, PhD, Frauke Bellos, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 615.

https://doi.org/10.1182/blood.V122.21.615.615

Published: 2013

Journal Articles

Flow Cytometric Assessment of the T-Cell Receptor Vβ Repertoire Identifies Clonal T-Cell Populations with High Specificity and Sensitivity.

Wolfgang Kern, MD, Frauke Bellos, MD, Sabine Jeromin, PhD, Tamara Alpermann, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 2661.

https://doi.org/10.1182/blood.V120.21.2661.2661

Published: 2012

Journal Articles

Flow Cytometric Assessment of Myeloid Nuclear Differentiation Antigen (MNDA) Expression in Myelodysplastic Syndromes As a Diagnostic Marker,

Wolfgang Kern, MD, Frauke Bellos, MD, Tamara Alpermann, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2011) 118 (21): 3805.

https://doi.org/10.1182/blood.V118.21.3805.3805

Published: 2011

Journal Articles

Frequency of Leukemia Stem Cell Candidates Predicts Refractoriness to Conventional Chemotherapy and Adverse Clinical Outcome

Dan Ran, MD, Isabel Taubert, Volker Eckstein, PhD, Frauke Bellos, MD, Patrick Wuchter, MD, Rainer Saffrich, PhD, Mario Schubert, MD, Anthony D. Ho, MD, FRCPC

Blood (2010) 116 (21): 2160.

https://doi.org/10.1182/blood.V116.21.2160.2160

Published: 2010

NARROW

Correlation of CD30 Expression on Neoplastic Mast Cells in Systemic Mastocytosis Assessed By Immunohistochemistry Versus Multiparameter Flow Cytometry and Correlation to Clinical Parameters

Myeloid Nuclear Differentiation Antigen (MNDA) Expression: A Useful Marker in the Diagnosis of Myelodysplastic Syndromes By Flow Cytometry

Assessment Of Human Equilibrative Nucleoside Transporter 1 (hENT1) – Expression By Flow Cytometry In Acute Myeloid Leukemia and Myelodysplastic Syndromes and Correlation To Clinical Outcome In Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy

Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency

Flow Cytometric Assessment of the T-Cell Receptor Vβ Repertoire Identifies Clonal T-Cell Populations with High Specificity and Sensitivity.

Flow Cytometric Assessment of Myeloid Nuclear Differentiation Antigen (MNDA) Expression in Myelodysplastic Syndromes As a Diagnostic Marker,

Frequency of Leukemia Stem Cell Candidates Predicts Refractoriness to Conventional Chemotherapy and Adverse Clinical Outcome

Email alerts

ASH Publications

American Society of Hematology

Correlation of CD30 Expression on Neoplastic Mast Cells in Systemic Mastocytosis Assessed By Immunohistochemistry Versus Multiparameter Flow Cytometry and Correlation to Clinical Parameters

Myeloid Nuclear Differentiation Antigen (MNDA) Expression: A Useful Marker in the Diagnosis of Myelodysplastic Syndromes By Flow Cytometry

Assessment Of Human Equilibrative Nucleoside Transporter 1 (hENT1) – Expression By Flow Cytometry In Acute Myeloid Leukemia and Myelodysplastic Syndromes and Correlation To Clinical Outcome In Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy

Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency

Flow Cytometric Assessment of the T-Cell Receptor Vβ Repertoire Identifies Clonal T-Cell Populations with High Specificity and Sensitivity.

Flow Cytometric Assessment of Myeloid Nuclear Differentiation Antigen (MNDA) Expression in Myelodysplastic Syndromes As a Diagnostic Marker,

Frequency of Leukemia Stem Cell Candidates Predicts Refractoriness to Conventional Chemotherapy and Adverse Clinical Outcome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only